Why the study?
Patients with acute myocardial infarction and hypertrophic cardiomyopathy have poor prognosis, but the impact of body mass index on their long-term outcomes remains unassessed.
Does obesity worsen long-term outcomes in hypertrophic cardiomyopathy patients with acute myocardial infarction?
Does obesity worsen long-term outcomes in hypertrophic cardiomyopathy patients with acute myocardial infarction?
Obesity is associated with a higher 5-year risk of major adverse cardiac events, including re-PCI and stroke, in patients with both hypertrophic cardiomyopathy and acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Obesity may heighten long-term MACE risk in HCM-AMI; leaves open whether targeted interventions improve outcomes.
BACKGROUND: Hypertrophic cardiomyopathy is associated with poor prognosis. In our previous study, it has been reported that patients with acute myocardial infarction and hypertrophic cardiomyopathy exhibited worse long-term outcomes than those with acute myocardial infarction without hypertrophic cardiomyopathy and those with hypertrophic cardiomyopathy without acute myocardial infarction. In this article, we aimed to assess the impact of body mass index on the long-term outcomes of hypertrophic cardiomyopathy patients with acute myocardial infarction. METHODS: adapted to Chinese. The long-term endpoints were major adverse cardiac events and secondary endpoints, which included re-hospitalization, recurrent angina, thrombosis, bleeding, heart failure, and arrhythmias. RESULTS: There were no differences in observed in-hospital mortality or 5-year mortality between the two groups of hypertrophic cardiomyopathy and acute myocardial infarction patients divided by body mass index. However, significantly increased incidence of re-percutaneous coronary intervention and stroke was observed in the obese group (re-percutaneous coronary intervention: 0.0% vs. 21.4%, p = 0.007; stroke: 5.6% vs. 28.6%, p = 0.042). The 5-year outcomes of major adverse cardiac events were inferior in the obese group (log-rank p = 0.020). CONCLUSION: Acute myocardial infarction and hypertrophic cardiomyopathy patients who were obese exhibited worse long-term outcomes than those without obesity.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: